7-Difluoromethoxy-5,4′-dimethoxy-genistein attenuates macrophages apoptosis to promote plaque stability via TIPE2/TLR4 axis in high fat diet-fed ApoE mice

Li Cong,Xiaolin Xie,Sujuan Liu,Liping Xiang,Yong Zhang,Jianguo Cao,Xiaohua Fu
DOI: https://doi.org/10.1016/j.intimp.2021.107477
IF: 5.714
2021-07-01
International Immunopharmacology
Abstract:<p>Promoting plaque stability is of great significance for prevention and treatment of cardiovascular diseases. 7-difluoromethoxy-5,4′-dimethoxygenistein (DFMG) is a novel active compound synthesized using genistein, which exerts anti-atherosclerotic effect. In this study, we evaluated effects of DFMG on plaque stability in <em>ApoE<sup>−/−</sup></em> mice fed with high fat diet (HFD), and explored the molecular mechanism by using <em>ApoE<sup>−/−</sup>TLR4<sup>−/−</sup></em> mice and RAW264.7 cells. Here, we found that DFMG significantly reduced plaque areas, macrophages infiltration and apoptosis, and TLR4 expression in HFD-fed <em>ApoE<sup>−/−</sup></em> mice. Meanwhile, DFMG increased collagen fibers, smooth muscle cells and TIPE2 expression in plaques and media. Besides, TLR4 knockout promoted the protective effects of DFMG on plaques. <em>In vitro</em>, DFMG decreased lysophosphatidylcholine (LPC)-induced macrophages apoptosis and TLR4, while upregulated TIPE2. Moreover, TIPE2 reduced TLR4, MyD88, p-NF-κB p65<sup>Ser276</sup>, cleaved Caspase-3 overproduction, and enhanced effects of DFMG on LPC-induced macrophages. Overall, our study demonstrates that DFMG can promote plaque stability by reducing macrophage apoptosis through TIPE2/TLR4 signaling pathway, which suggests DFMG should be used to develop food additives or drugs for preventing atherosclerosis.</p>
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?